19/07/2017
FIDIA FARMACEUTICI S.P.A. LEADS EUROPEAN ORTHOPEDIC BIOMATERIALS MARKET
Global viscosupplementation market is anticipated to increase to over $2.64 billion by 2021
PARSIPPANY, N.J.--(BUSINESS WIRE)--Fidia Farmaceutici S.p.A., a world leader in the research, development and manufacturing of hyaluronan (HA)-based products, and its wholly owned subsidiary, FIDIA PHARMA USA Inc., are projecting continued growth in 2017. The global viscosupplementation market is anticipated to increase to over $2.64 billion by 2021, according to a research study by RnR Market Research (1).